Studies using animal models have demonstrated the contribution of NLRP3 inflammasome activation to kidney inflammation, tubulointerstitial fibrosis, glomerulosclerosis, and progression of chronic kidney disease (CKD) [12,34]. Here, NLRP3 is linked to glomerulosclerosis.